✦ LIBER ✦

Risk factors and secondary prevention in women with heart disease: the heart and estrogen/progestin replacement study

✍ Scribed by E. Vittinghoff; M.G. Shlipak; P.D. Varosy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Placebo Adherence and Mortality in the H

✍ Padula, Amy M.; Pressman, Alice R.; Vittinghoff, Eric; Grady, Deborah; Neuhaus, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 528 KB

Postmenopausal hormone therapy and risk

✍ J.A Simon; J Hsia; J.A Cauley 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Lipid changes on hormone therapy and cor

✍ Michael G Shlipak; Lily A Chaput; Eric Vittinghoff; Feng Lin; Vera Bittner; Robe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Simulation of a putative susceptibility

✍ Bruce M. Psaty; Mary Cushman; Frits R. Rosendaal 📂 Article 📅 2001 🏛 John Wiley and Sons ⚖ 164 KB

The Relation of Postmenopausal Hormone T

✍ Joel A. Simon; Feng Lin; Eric Vittinghoff; Vera Bittner 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Prevention of Heart Disease in Women: Re

✍ Kathleen B. King; Lori Mosca 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 598 KB